Assenagon Asset Management S.A. Lowers Holdings in Outset Medical, Inc. (NASDAQ:OM)

Assenagon Asset Management S.A. reduced its stake in shares of Outset Medical, Inc. (NASDAQ:OM) by 27.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 289,783 shares of the company’s stock after selling 107,836 shares during the quarter. Assenagon Asset Management S.A. owned about 0.55% of Outset Medical worth $322,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of OM. Millennium Management LLC lifted its stake in Outset Medical by 58.8% in the second quarter. Millennium Management LLC now owns 1,942,899 shares of the company’s stock worth $7,480,000 after purchasing an additional 719,412 shares during the last quarter. GSA Capital Partners LLP lifted its stake in shares of Outset Medical by 924.7% during the 3rd quarter. GSA Capital Partners LLP now owns 1,111,612 shares of the company’s stock worth $753,000 after acquiring an additional 1,003,135 shares during the last quarter. Marshall Wace LLP lifted its stake in shares of Outset Medical by 487.8% during the 2nd quarter. Marshall Wace LLP now owns 314,187 shares of the company’s stock worth $1,210,000 after acquiring an additional 260,740 shares during the last quarter. Point72 Asset Management L.P. purchased a new position in Outset Medical during the 2nd quarter valued at $827,000. Finally, Cubist Systematic Strategies LLC grew its position in Outset Medical by 228.3% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 200,939 shares of the company’s stock valued at $774,000 after acquiring an additional 139,740 shares during the last quarter.

Insider Buying and Selling at Outset Medical

In other news, General Counsel John L. Brottem sold 32,930 shares of the business’s stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $0.80, for a total transaction of $26,344.00. Following the transaction, the general counsel now directly owns 181,188 shares in the company, valued at $144,950.40. The trade was a 15.38 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Nabeel Ahmed sold 34,288 shares of the firm’s stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $0.80, for a total value of $27,430.40. Following the completion of the sale, the chief financial officer now directly owns 258,869 shares of the company’s stock, valued at $207,095.20. This represents a 11.70 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 282,234 shares of company stock worth $233,798. 3.50% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada restated a “sector perform” rating and issued a $3.00 price target on shares of Outset Medical in a report on Tuesday, January 7th.

Outset Medical Trading Down 1.1 %

NASDAQ:OM opened at $0.85 on Friday. The stock has a fifty day moving average price of $1.01 and a 200 day moving average price of $1.24. The company has a current ratio of 6.49, a quick ratio of 5.04 and a debt-to-equity ratio of 4.12. Outset Medical, Inc. has a 12-month low of $0.44 and a 12-month high of $5.22. The firm has a market cap of $44.67 million, a PE ratio of -0.31 and a beta of 2.05.

Outset Medical Company Profile

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.